[HTML][HTML] Myocarditis and inflammatory cardiomyopathy: current evidence and future directions
Inflammatory cardiomyopathy, characterized by inflammatory cell infiltration into the
myocardium and a high risk of deteriorating cardiac function, has a heterogeneous …
myocardium and a high risk of deteriorating cardiac function, has a heterogeneous …
Cardiac fibrosis
NG Frangogiannis - Cardiovascular research, 2021 - academic.oup.com
Myocardial fibrosis, the expansion of the cardiac interstitium through deposition of
extracellular matrix proteins, is a common pathophysiologic companion of many different …
extracellular matrix proteins, is a common pathophysiologic companion of many different …
Cardiac natriuretic peptides
JP Goetze, BG Bruneau, HR Ramos, T Ogawa… - Nature Reviews …, 2020 - nature.com
Investigations into the mixed muscle–secretory phenotype of cardiomyocytes from the atrial
appendages of the heart led to the discovery that these cells produce, in a regulated …
appendages of the heart led to the discovery that these cells produce, in a regulated …
Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches
B López, S Ravassa, MU Moreno, GS José… - Nature Reviews …, 2021 - nature.com
Diffuse myocardial fibrosis resulting from the excessive deposition of collagen fibres through
the entire myocardium is encountered in a number of chronic cardiac diseases. This lesion …
the entire myocardium is encountered in a number of chronic cardiac diseases. This lesion …
Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy
AJ Marian, E Braunwald - Circulation research, 2017 - Am Heart Assoc
Hypertrophic cardiomyopathy (HCM) is a genetic disorder that is characterized by left
ventricular hypertrophy unexplained by secondary causes and a nondilated left ventricle …
ventricular hypertrophy unexplained by secondary causes and a nondilated left ventricle …
[HTML][HTML] Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for …
Parametric mapping techniques provide a non-invasive tool for quantifying tissue alterations
in myocardial disease in those eligible for cardiovascular magnetic resonance (CMR) …
in myocardial disease in those eligible for cardiovascular magnetic resonance (CMR) …
Myocardial interstitial fibrosis in heart failure: biological and translational perspectives
Myocardial interstitial fibrosis contributes to left ventricular dysfunction leading to the
development of heart failure. Basic research has provided abundant evidence for the …
development of heart failure. Basic research has provided abundant evidence for the …
T1 mapping in characterizing myocardial disease: a comprehensive review
VO Puntmann, E Peker, Y Chandrashekhar… - Circulation …, 2016 - Am Heart Assoc
Cardiovascular magnetic resonance provides insights into myocardial structure and function
noninvasively, with high diagnostic accuracy and without ionizing radiation. Myocardial …
noninvasively, with high diagnostic accuracy and without ionizing radiation. Myocardial …
Effects of sacubitril/valsartan on biomarkers of extracellular matrix regulation in patients with HFrEF
MR Zile, E O'Meara, B Claggett, MF Prescott… - Journal of the American …, 2019 - jacc.org
Background: Myocardial fibrosis is an important pathophysiological mechanism underlying
the development of heart failure (HF). Given the biochemical targets of sacubitril/valsartan …
the development of heart failure (HF). Given the biochemical targets of sacubitril/valsartan …
Myocardial tissue characterization and fibrosis by imaging
TD Karamitsos, A Arvanitaki, H Karvounis… - Cardiovascular …, 2020 - jacc.org
Myocardial fibrosis, either focal or diffuse, is a common feature of many cardiac diseases
and is associated with a poor prognosis for major adverse cardiovascular events. Although …
and is associated with a poor prognosis for major adverse cardiovascular events. Although …